Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors -- a meta-analysis of EFECT and SoFEA (CRUKE/03/021 & CRUK/09/007).
Saved in:
| Title: | Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors -- a meta-analysis of EFECT and SoFEA (CRUKE/03/021 & CRUK/09/007). |
|---|---|
| Authors: | Johnston, S. R. D., Chia, S., Kilburn, L. S., Gradishar, W. J., Cameron, D., Dodwell, D., Ellis, P., Howell, A., Im, Y.-H., Coombes, G., Piccart, M., Dowsett, M., Bliss, J. |
| Source: | Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p753-754. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
